IL17A and fungal infectious disease: The above studies clearly suggest that both neutrophils and IL-17 are responsible, in part, for the fibrosis development, evidence that supports the idea that neutrophils and/or IL-17 can be targets of a therapeutic intervention for the treatment of fibrosis as well as mycosis.